CUE: New Data (And Stock Highs) Coming?
Every time Cue Biopharma (CUE) attends a conference, management shares new platform-validating data. Here’s what to expect today…
CUE: Last Call To Back Up The Truck
Cue Biopharma (CUE) released a major, platform validating data this morning. Here are the 5 key takeaways…
CUE: The Data’s In… Kind Of
Cue Biopharma (CUE) released preliminary Phase 1A data this morning. There are several incremental updates. Here are the key takeways…
CUE: Here Comes The Data?
Cue Biopharma (CUE) is set to present interim Phase 1 data for CUE-101, which could start a rally that ulimately sees shares rise to $150. Here’s why…
CUE Q1 Preview: Data Release And Share Surge Imminent?
Cue Biopharma (CUE) is set to report Q1 2020 results. Here are six reasons why I expect positive data to come imminently and why shares could rally to $150+